Leading medicinal cannabis company Cannim has announced its UK operations will be based at Birmingham’s Precision Health Technologies Accelerator (PHTA), as part of a partnership aimed at furthering its research and improving patient outcomes. Cannim was established in Australia in 2017, curating products from across a network of EU GMP...
New sleep trial shows dramatic benefits for participants
Cambridge Sleep Sciences (CSS), a leading UK innovator in sleep technology, has announced groundbreaking results in a second trial of its pioneering SleepEngineTM technology, demonstrating the effectiveness of the technology in helping to improve the quality of adult sleep. The unique SleepEngineTM technology works by delivering a scientifically developed sequence...
Digital mental health technologies guidance launched to help manufacturers and safeguard users
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued new guidance to help manufacturers meet UK medical devices regulations and ensure digital mental health technologies are effective, reliable and acceptably safe. From mental health apps, AI-powered assessments, and virtual reality therapy, digital mental health technologies are increasingly used by...
Golden Ticket Programme 2025 crowns winner
Melio Bio, a biotech dedicated to the discovery and development of novel inhibitors targeting a receptor implicated in obesity and associated co-morbidities, has been revealed as the winner of Pioneer Group and Novo Nordisk’s 2025 Golden Ticket Programme. The 2025 Golden Ticket Programme was open to early-stage biotech companies focused...
Illuminating biology: Advanced imaging and computational techniques transforming medical research at the University of Warwick
Advances in imaging and computational techniques are enabling researchers to discover more than ever before about health and disease at cellular and molecular levels, whether observing cell structures with ultra precision, imaging biological processes in real-time or studying disease mechanisms. Advanced imaging is crucial in applications ranging from diagnostics to...
From firefighting to future-proofing: Why predictive compliance is key in medical device software
By Medilink Midlands Member Coauthor by Hindsight In today’s fast-paced and highly regulated world of medical device development, the importance of staying ahead of compliance and security challenges cannot be overstated. Yet, many manufacturers still adopt a reactive, "firefighting" approach to these challenges. They wait until vulnerabilities or compliance gaps...
IMed Consultancy new whitepaper reveals how to transform gruelling PMS procedures into commercial benefit
IMed Consultancy's new free whitepaper, "PMS from pain to potential: more than just ticking a box", reveals how to transform gruelling PMS procedures into commercial benefit. With evolving regulatory requirements such as the EU MDR 2017/745, EU IVDR 2017/746, and the UK PMS Statutory Instrument (SI), compliance has never been...
Upperton completes build of new £7m sterile manufacturing facility
A leading UK contract development and manufacturing organisation (CDMO) Upperton Pharma Solutions, has completed the build of its new sterile manufacturing facility in Nottingham. The new facility is in addition to its existing 50,000 sq. ft facility, Trent Gateway, and the purpose-built facility has been designed specifically in line with...
Insights from the 11th UK-China Economic and Financial Dialogue
Excellence First Enterprise Consultancy (EFEC) shares key insights from the recent 11th UK-China Economic and Financial Dialogue held on 11 January in Beijing. This high-level meeting, co-chaired by Chinese Vice Premier He Lifeng and UK Chancellor Rachel Reeves, covered a wide range of economic and financial cooperation areas. Key highlights...
Pioneer Group drives AI innovation in healthcare through industry and academic collaboration
Pioneer Group, the life science infrastructure and venture building specialist, has joined forces with Innovate UK, The Medical Research Council (MRC) and AstraZeneca, to deliver the AI in Health Accelerator 2024/2025 Programme. The Accelerator is designed to help entrepreneurs confidently market their AI-driven healthcare solutions and accelerate novel technology development...